115
Views
36
CrossRef citations to date
0
Altmetric
Review

Vaccine immunotherapy in breast cancer treatment: promising, but still early

, , , , &
Pages 1225-1241 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Fang Huang, Jinjin Zhao, Yiting Wei, Zhifa Wen, Yue Zhang, Xuru Wang, Yanfei Shen, Li-xin Wang & Ning Pan. (2020) Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells. International Journal of Nanomedicine 15, pages 1021-1035.
Read now
Amal Hasan, Hazem Ghebeh, Cynthia Lehe, Rasheed Ahmad & Said Dermime. (2011) Therapeutic targeting of B7-H1 in breast cancer. Expert Opinion on Therapeutic Targets 15:10, pages 1211-1225.
Read now
Elda Tagliabue, Andrea Balsari, Manuela Campiglio & Serenella M Pupa. (2010) HER2 as a target for breast cancer therapy. Expert Opinion on Biological Therapy 10:5, pages 711-724.
Read now

Articles from other publishers (32)

Jingya Zhang, Yongbo Lu, Ning Zhang, Zeru Yu, Haorao Li, Rongxin He, Ying Mao & Bin Zhu. (2023) Global burden of female breast cancer and its association with socioeconomic development status, 1990–2044. Cancer Reports 6:S1.
Crossref
Nikoleta Sjekloča, Snjezana Tomić, Ivana Mrklić, Filip Vukmirović, Ljiljana Vučković, Ingrid Belas Lovasić & Marina Maras-Šimunić. (2020) Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer. Medicine 99:7, pages e19091.
Crossref
Giuseppe Curigliano, Vincenzo Bagnardi, Mariacristina Ghioni, Jamila Louahed, Vincent Brichard, Frederic F. Lehmann, Antonio Marra, Dario Trapani, Carmen Criscitiello & Giuseppe Viale. (2020) Expression of tumor-associated antigens in breast cancer subtypes. The Breast 49, pages 202-209.
Crossref
Jingkun Qu, Xixi Zhao, Jizhao Wang, Chao Liu, Yuchen Sun, Hui Cai & Jianlin Liu. (2018) Plasma phospholipase A2 activity may serve as a novel diagnostic biomarker for the diagnosis of breast cancer. Oncology Letters.
Crossref
Kenji Gonda, Masahiko Shibata, Tohru Ohtake, Yoshiko Matsumoto, Kazunoshin Tachibana, Noriko Abe, Hitoshi Ohto, Kenichi Sakurai & Seiichi Takenoshita. (2017) Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer. Oncology Letters 14:2, pages 1766-1774.
Crossref
Yao-Min Chen, Yu Liu, Hai-Yan Wei, Ke-Zhen Lv & Peifen Fu. (2016) Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells. Tumor Biology 37:8, pages 10861-10870.
Crossref
Hua Yang, Craig M. Brackett, Vanessa Marie Morales-Tirado, Zezhong Li, Qing Zhang, Matthew W. Wilson, Camille Benjamin, Wayne Harris, Edmund K. Waller, Andrei V. Gudkov, Lyudmila G. Burdelya & Hans E. Grossniklaus. (2015) The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism. Oncotarget 7:3, pages 2936-2950.
Crossref
Abbas Ali Imani Fooladi, Raheleh Halabian, Mehdi Mahdavi, Mohsen Amin & Hamideh Mahmoodzadeh Hosseini. (2015) Staphylococcal enterotoxin B/texosomes as a candidate for breast cancer immunotherapy. Tumor Biology 37:1, pages 739-748.
Crossref
Yi Huang, Chunling Ma, Qunyuan Zhang, Jian Ye, Fang Wang, Yanping Zhang, Pamela Hunborg, Mark A. Varvares, Daniel F. Hoft, Eddy C. Hsueh & Guangyong Peng. (2015) CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome. Oncotarget 6:19, pages 17462-17478.
Crossref
Hongyan Ren, Simin Zhao, Weixia Li, Huixia Dong, Meng Zhou, Meng Cao, Hong-Ming Hu & Li-xin Wang. (2014) Therapeutic Antitumor Efficacy of B Cells Loaded With Tumor-derived Autophagasomes Vaccine (DRibbles). Journal of Immunotherapy 37:8, pages 383-393.
Crossref
Peng Zhang, Shuhong Yi, Xi Li, Ruilei Liu, Hua Jiang, Zenan Huang, Yu Liu, Juekun Wu & Yong Huang. (2014) Preparation of Triple-Negative Breast Cancer Vaccine through Electrofusion with Day-3 Dendritic Cells. PLoS ONE 9:7, pages e102197.
Crossref
Edward L Nelson. (2014) HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium. Clinical Investigation 4:7, pages 649-671.
Crossref
Shao-ying Li, Rong Li, Yu-li Chen, Li-kuang Xiong, Hui-lin Wang, Lei Rong & Rong-cheng Luo. (2014) Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients. BMC Genetics 15:1, pages 67.
Crossref
Huseyin Engin, Cemil Bilir & Ishak Ozel Tekin. (2013) Prognostic Significance of Peripheral Blood Flow Cytometry Parameters in Patients with Non-Metastatic Breast Cancer. Asian Pacific Journal of Cancer Prevention 14:12, pages 7645-7649.
Crossref
Lyudmila G. BurdelyaCraig M. BrackettBojidar KojouharovIlya I. GitlinKaterina I. LeonovaAnatoli S. GleibermanSemra Aygun-SunarJean VeithChristopher JohnsonGary J. HaderskiPatricia Stanhope-BakerShyam AllamaneniJoseph SkitzkiMing Zeng, Elena Martsen, Alexander Medvedev, Dmitry Scheblyakov, Nataliya M. Artemicheva, Denis Y. Logunov, Alexander L. Gintsburg, Boris S. Naroditsky, Sergei S. Makarov & Andrei V. Gudkov. (2013) Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist. Proceedings of the National Academy of Sciences 110:20.
Crossref
Philippe Monnier, Robin Vigouroux & Nardos Tassew. (2013) In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments. Antibodies 2:4, pages 193-208.
Crossref
Yuhuan Li, Li-Xin Wang, Puiyi Pang, Zhihua Cui, Sandra Aung, Daniel Haley, Bernard A. Fox, Walter J. Urba & Hong-Ming Hu. (2011) Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy. Clinical Cancer Research 17:22, pages 7047-7057.
Crossref
Sahar M.A. MahmoudEmma Claire PaishDesmond G. PoweR. Douglas MacmillanMatthew J. GraingeAndrew H.S. LeeIan O. EllisAndrew R. Green. (2011) Tumor-Infiltrating CD8 + Lymphocytes Predict Clinical Outcome in Breast Cancer . Journal of Clinical Oncology 29:15, pages 1949-1955.
Crossref
Min-Ho Park, Deok-Hwan Yang, Mi-Hyun Kim, Jae-Hong Jang, Yoon-Young Jang, Youn-Kyung Lee, Chun-Ji Jin, Than Nhan Nguyen Pham, Truc Anh Nguyen Thi, Mi-Seon Lim, Hyun-Ju Lee, Cheol Yi Hong, Jung-Han Yoon & Je-Jung Lee. (2011) Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer. Cancer Research and Treatment 43:1, pages 56-66.
Crossref
Maha Z Ladjemi, Thierry Chardes, Stephanie Corgnac, Veronique Garambois, Sebastien Morisseau, Bruno Robert, Caroline Bascoul-Mollevi, Imade Ait Arsa, William Jacot, Jean-Pierre Pouget, Andre Pelegrin & Isabelle Navarro-Teulon. (2011) Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice. Breast Cancer Research 13:1.
Crossref
G. Curigliano, G. Viale, M. Ghioni, A.A. Jungbluth, V. Bagnardi, G.C. Spagnoli, A.M. Neville, F. Nolè, N. Rotmensz & A. Goldhirsch. (2011) Cancer–testis antigen expression in triple-negative breast cancer. Annals of Oncology 22:1, pages 98-103.
Crossref
Teresa Gilewski. (2010) Targeting the Immune System as a Therapeutic Strategy for Patients with Breast Cancer. Current Breast Cancer Reports 2:4, pages 214-221.
Crossref
Tetsuya Yoshida, Ryoko Yoshida, Bruce Yong Ma, Sebastian Mikolajczak, David J. Kelvin & Atsuo Ochi. (2010) A novel mitogen fusion protein against CD40+ cells with potent vaccine adjuvant properties. Vaccine 28:21, pages 3688-3695.
Crossref
Jinze Li & Jack P. Uetrecht. 2010. Adverse Drug Reactions. Adverse Drug Reactions 493 509 .
Barbara Seliger. 2009. Tumor‐Associated Antigens. Tumor‐Associated Antigens 219 229 .
Luigi Aurisicchio, Daniela Peruzzi, Antonella Conforti, Sridhar Dharmapuri, Antonella Biondo, Saverio Giampaoli, Arthur Fridman, Ansu Bagchi, Christopher T. Winkelmann, Raymond Gibson, Ekambar R. Kandimalla, Sudhir Agrawal, Gennaro Ciliberto & Nicola La Monica. (2009) Treatment of Mammary Carcinomas in HER-2 Transgenic Mice through Combination of Genetic Vaccine and an Agonist of Toll-Like Receptor 9. Clinical Cancer Research 15:5, pages 1575-1584.
Crossref
Elena FattoriLuigi AurisicchioImmacolata ZampaglioneMirko ArcuriManuela CappellettiBarbara CiprianiCarmela MennuniFrancesco CalvarusoMaurizio NuzzoGennaro CilibertoPaolo MonaciNicola La Monica. (2009) ErbB2 Genetic Cancer Vaccine in Nonhuman Primates: Relevance of Single Nucleotide Polymorphisms. Human Gene Therapy 20:3, pages 253-265.
Crossref
. (2009) Current World Literature. Current Opinion in Obstetrics & Gynecology 21:1, pages 101-109.
Crossref
Nowruz Delirezh, Seyed Mohammad Moazzeni, Fazel Shokri, Mohammad Ali Shokrgozar, Morteza Atri & Parviz Kokhaei. (2009) Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro. Cellular Immunology 257:1-2, pages 23-31.
Crossref
William E. Gillanders, Peter S. Goedegebuure & Timothy J. Eberlein. 2009. The Breast. The Breast 595 601 .
Hazem Ghebeh, Eman Barhoush, Asma Tulbah, Naser Elkum, Taher Al-Tweigeri & Said Dermime. (2008) FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy. BMC Cancer 8:1.
Crossref
. (2008) Current World Literature. Current Opinion in Allergy & Clinical Immunology 8:6, pages 590-596.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.